Senti Biosciences
SNTI
SNTI
15 hedge funds and large institutions have $14.2M invested in Senti Biosciences in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
5
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$1.88M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$436K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$248K |
| 4 |
BlackRock
New York
|
+$38.1K |
| 5 |
Barclays
London,
United Kingdom
|
+$947 |
Top Sellers
| 1 |
HCM
Heights Capital Management
San Francisco,
California
|
-$778K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$82.4K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$21.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$641 |
| 5 |
JPMorgan Chase & Co
New York
|
-$30 |
